GO:0086060 voltage-gated sodium channel activity involved in AV node cell action potential

The atrioventricular (AV) node is a specialized cardiac structure that delays and regulates electrical conduction between the atria and ventricles. The molecular function defined by GO:0086060, voltage-gated sodium channel activity involved in AV node cell action potential, refers to the transmembrane transfer of sodium ions through voltage-gated channels in AV node cardiac muscle cells, contributing to the depolarization phase of the action potential. This activity is distinct from other sodium channel functions because it is spatially and temporally restricted to AV node cells and is essential for proper cardiac rhythm. Researchers study this term to understand the ionic basis of AV node conduction and its role in arrhythmogenesis. Unlike working cardiomyocytes, where sodium channels are abundant and produce fast upstrokes, AV node cells exhibit smaller and slower sodium currents, making them highly sensitive to modulation. The Notch signaling pathway has been shown to reprogram cardiomyocytes to a conduction-like phenotype, altering the expression of ion channels including voltage-gated sodium channels, which may influence AV node function. This highlights the importance of transcriptional and signaling networks in regulating GO:0086060. Understanding this molecular function is critical for developing targeted therapies for conduction disorders and for interpreting genetic variants associated with arrhythmias. Advances in CRISPR gene editing and stem cell technologies now allow researchers to model AV node-specific sodium channel activity in vitro and in vivo. By knocking out or mutating genes encoding channel subunits, scientists can determine their precise contribution to AV node action potentials and identify novel therapeutic targets. This article provides a comprehensive overview of GO:0086060, including its definition, mechanism, key genes, disease relevance, and state-of-the-art research methods.

GO:0086060 is a molecular function term that describes the voltage-gated sodium channel activity specifically occurring in the plasma membrane of AV node cardiac muscle cells. It enables the transmembrane transfer of sodium ions through a voltage-gated channel, contributing to the depolarization phase of an action potential. The channel's open state depends on the voltage across the membrane, and this activity is distinct from sodium channel activities in other cardiac cell types or tissues.

GO:0086060 is critical for normal cardiac conduction because it governs the rapid depolarization phase of AV node action potentials, which determines the speed and reliability of electrical signal transmission from atria to ventricles. Dysfunction of this activity can lead to life-threatening arrhythmias, including atrioventricular block and ventricular arrhythmias. Understanding the molecular players and regulatory mechanisms of this term is essential for developing gene-based therapies and for interpreting genetic variants in channel-encoding genes.

The following genes encode subunits or regulators of voltage-gated sodium channels that contribute to GO:0086060 in AV node cells.

The activity of voltage-gated sodium channels in AV node cells is regulated at multiple levels. Transcriptional control by Notch signaling can reprogram cardiomyocytes toward a conduction-like phenotype, altering the expression of sodium channel genes. Post-translational modifications, such as phosphorylation by protein kinases, modulate channel gating and trafficking. Auxiliary subunits (e.g., SCN1B-SCN4B) and interacting proteins like calmodulin (CALM1-3) and FGF12 regulate channel inactivation and surface expression. These regulatory mechanisms ensure proper AV node conduction and are disrupted in various arrhythmia syndromes.

Dysfunction of voltage-gated sodium channels in the AV node can lead to atrioventricular block, a condition where electrical signals from the atria fail to reach the ventricles properly. Mutations in SCN5A, the gene encoding the primary cardiac sodium channel alpha subunit, are associated with progressive cardiac conduction defects and AV block. Reduced sodium current in AV node cells slows conduction and can cause syncope or sudden cardiac death.

Brugada syndrome is an inherited arrhythmia disorder characterized by ST-segment elevation and increased risk of ventricular fibrillation. Loss-of-function mutations in SCN5A reduce sodium current, and although the primary phenotype involves the right ventricle, conduction abnormalities in the AV node may contribute to arrhythmogenesis. Understanding AV node-specific sodium channel activity (GO:0086060) is important for risk stratification and therapy.

Sick sinus syndrome and atrial fibrillation often involve conduction system dysfunction. Variants in SCN5A and auxiliary subunits have been linked to these conditions. Altered sodium channel activity in the AV node can affect ventricular rate during atrial fibrillation, making it a target for rate control strategies. Notch-mediated reprogramming of cardiomyocytes may also play a role in the pathogenesis of conduction system diseases.

Patch clamp recording is the gold standard for measuring voltage-gated sodium channel activity in AV node cells. It allows direct assessment of sodium current amplitude, voltage dependence of activation and inactivation, and kinetics. This method can be applied to isolated AV node cells, hiPSC-derived cardiomyocytes, or heterologous expression systems. It is essential for validating the functional impact of genetic variants in SCN5A and auxiliary subunits.

CRISPR-Cas9 enables precise knockout, knock-in, or point mutation of genes encoding sodium channel subunits. In the context of GO:0086060, researchers can generate isogenic hiPSC lines carrying patient-specific mutations to study their effects on AV node action potentials. This approach provides a causal link between genotype and electrophysiological phenotype.

RNA-seq can quantify the expression of sodium channel genes and identify alternative splicing events in AV node cells. It is useful for comparing transcriptomes of AV node versus working cardiomyocytes and for assessing the impact of Notch signaling on ion channel gene expression. This method helps identify novel regulators of GO:0086060.

Optical mapping using voltage-sensitive dyes allows visualization of action potential propagation in AV node tissue or hiPSC-derived cardiac clusters. Calcium imaging can assess excitation-contraction coupling. These techniques provide spatial and temporal information about conduction and can reveal abnormalities linked to sodium channel dysfunction.

Researchers studying voltage-gated sodium channel activity involved in AV node cell action potential-related genes often need to determine whether a candidate gene is causally involved in channel function, conduction, or disease. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this discovery process, from knockout to precise point mutations and library screening.

GO:0086060, voltage-gated sodium channel activity involved in AV node cell action potential, is a specialized molecular function critical for normal cardiac conduction. Its precise regulation by channel subunits, auxiliary proteins, and signaling pathways ensures reliable electrical signaling through the AV node. Dysregulation leads to serious arrhythmias, making it a key target for research and therapeutic development. Advances in CRISPR gene editing and stem cell models now enable detailed dissection of this function, offering new opportunities for precision medicine in cardiac electrophysiology.